Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe (Primary) | PRIMARYEUR | Univ | 6,300 | 19,514,539 | -0.50% | -1.15% | 1.09% | 9.69% | 6.15% | 9.38% |
Healthcare | HEALTHCARE | Sector | 576 | 2,124,848 | -0.10% | -0.73% | -1.61% | 6.44% | -5.07% | -13.78% |
Biopharmaceuticals | BIOPHARMA | SubSec | 183 | 1,621,869 | -0.13% | -0.70% | -2.42% | 5.90% | -5.60% | -18.56% |
Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 55 | 33,093 | 1.97% | 2.55% | 0.23% | 12.76% | -5.03% | -12.87% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 12 | 4,053 | 0.89% | 7.55% | 5.72% | 16.99% | 4.18% | -1.49% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,300 | 19,514,539 | -0.70% | -1.64% | -0.04% | 7.99% | 5.36% | 7.93% |
Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,207 | 0.75% | 3.56% | 3.97% | 24.98% | -6.74% | 2.25% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 12 | 4,053 | 0.89% | 7.55% | 5.72% | 16.99% | 4.18% | -1.49% |
Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 825 | 2.44% | 14.98% | 7.71% | 32.76% | 34.40% | 32.76% |
Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 520 | -1.08% | 13.90% | 10.25% | -8.26% | 32.92% | -20.50% |
* Colors indicate performance relative to the benchmark.